Home › Subarachnoid Hemorrhage › NCT04557618
Auricular VNS Following Subarachnoid Hemorrhage
Recruiting
Transcutaneous Auricular Vagus Nerve Stimulation Following Spontaneous Subarachnoid Hemorrhage
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Spontaneous subarachnoid hemorrhage Exclusion Criteria: * Trauma-induced subarachnoid hemorrhage * Ongoing chemotherapy * Taking immunosuppressive medications for other medical illnesses * Presence of a pacemaker * Prolonged bradycardia at time of admission
About the study
This study will evaluate whether non-invasive auricular vagal nerve stimulation lowers inflammatory markers, and improves outcomes following spontaneous subarachnoid hemorrhage.
What is being tested
- Auricular Vagus Nerve Stimulation (device)
- Sham Auricular Vagus nerve Stimulation (device)
Sponsor: Anna Huguenard · Participants: 50 · Started: Jan 5, 2021
Contact the study team
- Anna L Huguenard, MD · Phone: 3144506698
Official record on ClinicalTrials.gov — NCT04557618
Locations in the U.S.
| Missouri | Washington University School of Medicine, St Louis |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.